康美药业：拟与关联方广药集团签订和解协议 以4350万元解决历史债务问题

Core Viewpoint - Kangmei Pharmaceutical plans to sign a settlement agreement with its affiliate Guangzhou Pharmaceutical Group to resolve historical debt issues for 43.5 million yuan [1] Group 1 - The subsidiary Chengdu Kangmei Pharmaceutical intends to pay 43.5 million yuan along with related fees to settle the debt [1] - After the payment is completed, Guangzhou Pharmaceutical Group will assist Chengdu Kangmei in handling the execution unsealing and case closure procedures [1] - This transaction is classified as a related party transaction but does not constitute a major asset restructuring [1]